Strategies for Identification, Isolation, and Treatment of Special Pathogens / COVID-19 and Sepsis: Similarities and Differences
Strategies for Identification, Isolation, and Treatment of Special Pathogens
The coronavirus disease (COVID-19) was designated as a pandemic threat in early 2020. In less than a year, this pathogen went from an emerging threat to one affecting millions of people around the world. The National Emerging Special Pathogens Training and Education Center (NETEC) aims to increase the capability of public health and healthcare systems to safely and effectively manage individuals with suspected and confirmed pathogens. This session will discuss the role of NETEC in emerging pathogens and COVID-19. You will also learn about the unique features and most recent information about COVID-19.
COVID-19 and Sepsis: Similarities and Differences
Since coronavirus disease 2019 (COVID-19) was first reported in December 2019 in Wuhan, China, clinicians have tried to understand this new disease. Today much more is known about it, but there still remains a great deal to learn. This session will discuss the most recent information about COVID-19 and its connection to sepsis. Learn about the clinical care implications, including what to apply in practice for optimal patient care. The unique features and phenotypes of COVID-19 will also be reviewed.
This course was originally recorded in September 2020 as part of the 2020 Sepsis Alliance Summit.
Nurses, physicians, pharmacists, emergency responders, healthcare management teams, and other healthcare staff may benefit.
At the end of the presentation, the attendee should be able to:
- Define the criteria for a special pathogen.
- Discuss the outbreak history of COVID-19, MERS, and Ebola Virus Disease.
- Provide an overview of key facts of COVID-19, MERS, and Ebola such as mortality, virus type, and population at risk.
- Define COVID-19 and sepsis.
- Discuss clinical care implications for COVID-19 and sepsis.
- Identify unique features and phenotypes of COVID-19.
Radu Postelnicu, MD
Assistant Professor of Medicine, NYU School of Medicine; Associate Director, Bellevue Medical ICU; Assistant Program Director, NYU Pulmonary/ Critical Care Fellowship
Dr. Postelnicu is an Assistant Professor of Medicine at New York University School of Medicine and the Associate Director of the Medical ICU at Bellevue Hospital and Assistant Program Director for the NYU Pulmonary and Critical Care Medicine fellowship program. He earned his BA at Northwestern University and his MD at Tulane University School of Medicine. Dr. Postelnicu did his residency in internal medicine at NYU School of Medicine, where he also completed pulmonary and critical care medicine fellowship training. His interests focus on long-term consequences of sepsis and critical illness, as well as patient safety and quality improvement. He is actively involved in several professional societies as well as in the National Emerging Special Pathogens Training and Education Center (NETEC).
Patricia Ann Tennill RN, BSN, BS H.Ec
Associate Director of Nursing, New York Health and Hospitals/Bellevue
Patricia is an Associate Director of Nursing in Staff Development and the nursing lead for the NYC Health and Hospitals/Bellevue Special Pathogens Program. There she works to develop protocols concerning the movement and care of patients with special pathogens and subsequent hands-on training for all staff involved the Special Pathogens Program. Patricia also trains staff in PPE donning and doffing for all pathogens of concern. She has been involved with the Special Pathogens Program since 2014 as a nurse leader responsible for coordinating and overseeing all nursing operations on the Special Pathogens Unit. She graduated from The Ohio State University with a degree in Home Economics specializing in nutrition and then several years later University of Massachusetts with a degree in nursing. Her career began in Manhattan working with HIV patients at St. Vincent’s Hospital and then served as Assistant Head Nurse in the surgical intensive care unit (ICU). Since coming to Bellevue Hospital in 2010, Patricia was in leadership roles in the medical and neurosurgical ICUs. After the Ebola epidemic she became an Associate Director of Nursing and the Nurse Lead for the Special Pathogens Program. She is a member of NETEC, where she is the Task Lead for Infection Prevention, Simulation and Skills, and a Subject Matter Expert.
Greg S. Martin, M.D., M.Sc., FCCM, FCCP, ATS-F
Professor of Pulmonary and Critical Care Medicine, Emory University; President-Elect, Society of Critical Care Medicine
Greg S. Martin, M.D., M.Sc. is Professor of Medicine and Executive Associate Division Director at Emory University in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine. Dr. Martin is the Research Director for the Emory Critical Care Center (ECCC), Director of the Emory/Georgia Tech Predictive Health Institute, chair of the Critical Care Committee at Grady Memorial Hospital, and Co-Director of the Atlanta Center for Microsystems Engineered Point-of-Care Technologies program charged with accelerating COVID-19 diagnostics in the NIH RADx program. Dr. Martin’s research focuses on sepsis and the acute respiratory distress syndrome (ARDS) and spans epidemiology and health services research through device platforms and biomarker studies to randomized trials of new treatments. He is a member of several professional societies and will serve in 2021 as President for the Society of Critical Care Medicine.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.
Other healthcare providers will receive a certificate of attendance for 1.25 contact hours.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- 1.25 Participation
- 1.60 RN CE Contact HoursProvider approved by the California Board of Registered Nursing, Provider Number CEP17068.